ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,268.19
1.00%
Dow Jones
39,935.07
0.00%
Gold vs US Dollar
2,377.23
0.55%
Brent Oil
80.725
-0.99%
Bitcoin
67,301.44
2.30%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Genfit (XUP) Share Price

XUP Genfit

4.14
0.075 (1.85%)
14:20:12 - Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Genfit TG:XUP Tradegate (DE) Ordinary Share FR0004163111 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   0.075 1.85 4.14 4.01 4.05 4.14 4.14 4.1399999 725 13:20:12   
 Type  Size  Price  Time  Units 
  725 4.14 11:48:08 EUR
 
Recent News
DateTimeSource
HeadlineMore XUP News
26/07/202412:45UKREGGENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive
26/07/202412:45UKREGGENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
09/07/202421:10UKREGGENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
09/07/202421:10UKREGGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
17/06/202421:10GLOBEGENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque  
17/06/202421:10GLOBEGENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
10/06/202422:22GLOBEGENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine
Period
Draw mode
Data Downloads for XUP

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Genfit Articles